# Lanxess Group Lanxess Group is a Corporate Investor based in Cologne, Germany. ## Overview - **Organization type:** Corporate Investor - **Headquarters:** Cologne, Germany - **Region:** Europe - **Address:** Cologne, Germany - **Founded:** 2004 - **Assets under management:** Undisclosed - **Website:** lanxess.com - **LinkedIn:** https://www.linkedin.com/company/lanxess ## Regulatory record - **Reports private funds:** No ## About Lanxess was formed in 2004 when Bayer AG spun off its chemical operations and a substantial portion of its polymer activities, creating a pure-play specialty chemicals company under the leadership of CEO Matthias Zachert. Headquartered in Cologne, the group was built to shed conglomerate inertia, focusing instead on the development, manufacture, and sale of chemical intermediates, additives, and performance plastics. The corporate separation gave Lanxess a clean operational mandate unburdened by Bayer's pharmaceutical and agricultural divisions. The company's strategy targets high-margin niches within specialty chemicals, organized into three principal segments: Consumer Protection, Specialty Additives, and Advanced Industrial Intermediates. These cover a wide asset-class mix including flame retardants, water treatment chemicals, rubber additives, high-performance plastics, and microbial control products. Lanxess typically deploys capital through direct organic investment in existing production sites and selective bolt-on acquisitions rather than fund commitments. Its industrial footprint spans major production facilities in Leverkusen, Germany; El Dorado, Arkansas; Jhagadia, India; and Changzhou, China. A confirmed co-investor relationship exists with Greenlight Capital, whose founder David Einhorn held a disclosed 5.06% stake in Lanxess AG, signaling activist interest in the firm's operational efficiency. The group employs roughly 13,000 people globally and generates annual revenues of €6.7 billion (per the firm, 2023). In May 2024, Lanxess maintained its strategic pivot toward consumer protection products following a period of demand normalization in the specialty additives segment. Beyond its core industrial operations, Lanxess participates in several multilateral sustainability bodies, including the World Business Council for Sustainable Development and the United Nations Global Compact, while the Lanxess Foundation operates in Canada. The company also holds a membership in the Federation of German Industries' Circular Economy initiative. Lanxess's structural differentiator lies in its origin as a corporate spin-off, which has shaped a governance and operational culture distinct from family-founded chemical dynasties. The firm is publicly traded, subject to shareholder activism from entities like Greenlight Capital, and must justify its portfolio composition to a public market rather than a single family. This accountability, combined with a production-heavy asset base across four continents, yields a risk profile closer to an operating company than a capital allocator, where value is driven by plant efficiency and specialty-chemical IP rather than fund-selection skill. ## Sectors - Specialty Chemicals - Industrial Tech - Energy Transition & Renewables - Mobility & Transportation ## Offices - Leverkusen, Germany - El Dorado, Arkansas, United States - Jhagadia, Gujarat, India - Changzhou, China ## People - Matthias Zachert — CEO and Chairman of the Board of Management ## Questions ### What does Lanxess actually produce and sell? Lanxess manufactures specialty chemicals across three main segments: Consumer Protection, Specialty Additives, and Advanced Industrial Intermediates. Its products include flame retardants, antimicrobial agents, water treatment chemicals, high-performance plastics, and rubber additives. These are sold predominantly to industrial customers in the automotive, construction, electronics, and agricultural sectors. ### Does Lanxess invest in external funds or only direct operations? Lanxess deploys its capital almost exclusively into direct operating assets, including owned production sites and bolt-on corporate acquisitions. There is no publicly disclosed fund-of-funds or limited partner program. The firm's investment model is that of a strategic corporate acquirer and plant operator, not an institutional allocator to external managers. ### Which sectors does Lanxess explicitly avoid? Lanxess does not participate in pharmaceuticals, agricultural chemicals, or consumer health products, which remained with former parent Bayer AG after the 2004 spin-off. The company's mandate is deliberately restricted to industrial intermediates, additives, and performance materials, avoiding the biotech and crop-science adjacency where Bayer still operates. ### What is Lanxess's known posture on co-investments? Lanxess does not operate a co-investment platform or syndicate with external financial GPs. Its industrial logic treats production sites and corporate acquisitions as primary vehicles. The firm's relationship with Greenlight Capital represents shareholder engagement from a public-equity activist, not a direct co-investment partnership in private transactions. ## Related profiles - [Lantmännens Gemensamma Pensionsstiftelse Grodden](https://altss.com/profile/lantm-nnens-gemensamma-pensionsstiftelse-grodden) - [Lao Niu Foundation](https://altss.com/profile/lao-niu-foundation) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/lanxess-group Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology